Nicole Amy Doria-Rose (born 1970)[1] is an American biologist. She is chief of the humoral immunology core at the Vaccine Research Center. She develops and applies assays to evaluate HIV-1 specific antibody responses during natural infection and after immunization.
Nicole Doria-Rose | |
|---|---|
.jpg) Doria-Rose in 2021 | |
| Born | 1970 (age 53–54) |
| Alma mater | Cornell University (BA, PhD) |
| Scientific career | |
| Fields | Humoral immunity |
| Institutions | Vaccine Research Center |
| Thesis | In vivo selection of Rous sarcoma virus mutants with randomized sequences in the packaging signal (1998) |
| Doctoral advisor | Volker Vogt |
Education
editDoria-Rose graduated from Hunter College High School in New York City in 1987. She obtained her Bachelor of Arts in biology in 1991 and a Ph.D. in 1998 from Cornell University. During her doctoral studies, she trained under advisor Volker Vogt in the department of biochemistry, molecular and cell biology.[2] Her dissertation was titled In vivo selection of Rous sarcoma virus mutants with randomized sequences in the packaging signal.[1]
From 1998 to 2003, Doria-Rose worked as a postdoctoral scientist in the laboratory of Nancy Haigwood at the Seattle Biomedical Research Institute (SBRI) and the department of pathobiology at University of Washington. Doria-Rose was promoted to the position of associate scientist at SBRI in 2003. While working as a post-doctoral fellow, Doria-Rose was also appointed as associate faculty in the science department at Shoreline Community College in 2000.[2]
Career
editDoria-Rose joined the National Institute of Allergy and Infectious Diseases in 2006 as a senior research fellow in the laboratory of immunoregulation. In 2011, she became a staff scientist at the Vaccine Research Center, where she has worked on isolating new, potent anti-HIV monoclonal antibodies and studying their development over time. In 2012, she was promoted to the position of Chief of the humoral immunology core.[2]
Doria-Rose develops and applies assays to evaluate HIV-1 specific antibody responses during natural infection and after immunization.[2]
References
edit- ^ a b Doria-Rose, Nicole Amy (1998). In vivo selection of Rous sarcoma virus mutants with randomized sequences in the packaging signal. Vol. 72. pp. 8073–8082. doi:10.1128/JVI.72.10.8073-8082.1998. ISBN 978-0-591-84032-2. OCLC 841778470. PMC 110144. PMID 9733847.
{{cite book}}:|journal=ignored (help) - ^ a b c d "Nicole Doria-Rose, Ph.D. | NIH: National Institute of Allergy and Infectious Diseases". www.niaid.nih.gov. Retrieved 2020-04-01.
This article incorporates public domain material from websites or documents of the National Institutes of Health.